Insulin secretagogues

MJ Davies - Current Medical Research and Opinion, 2002 - Taylor & Francis
Existing oral insulin secretagogues, sulphonylureas, are associated with hyperinsulinaemia,
risk of hypoglycaemia and weight gain. Furthermore, they are not able to offer durable …
被引用次数：42 相关文章

[引用][C] Insulin secretagogues

MJ DAVIES - Current medical research and opinion …, 2002 - pascal-francis.inist.fr
Insulin secretagogues CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic
Databases Simple search Advanced search Search by classification Search by vocabulary …

Insulin secretagogues

MJ Davies - Current Medical Research and Opinion, 2002 - hero.epa.gov
Existing oral insulin secretagogues, sulphonylureas, are associated with hyperinsulinaemia,
risk of hypoglycaemia and weight gain. Furthermore, they are not able to offer durable …

Insulin secretagogues.

MJ Davies - Current Medical Research and Opinion, 2002 - europepmc.org
Existing oral insulin secretagogues, sulphonylureas, are associated with hyperinsulinaemia,
risk of hypoglycaemia and weight gain. Furthermore, they are not able to offer durable …

Insulin secretagogues

MJ Davies - Current Medical Research and Opinion, 2002 - search.proquest.com
Existing oral insulin secretagogues, sulphonylureas, are associated with hyperinsulinaemia,
risk of hypoglycaemia and weight gain. Furthermore, they are not able to offer durable …

Insulin secretagogues

MJ Davies - Current medical research and opinion, 2002 - pubmed.ncbi.nlm.nih.gov
Existing oral insulin secretagogues, sulphonylureas, are associated with hyperinsulinaemia,
risk of hypoglycaemia and weight gain. Furthermore, they are not able to offer durable …

[引用][C] Insulin secretagogues

MJ DAVIES - Current medical research and opinion. Supplement, 2002 - Librapharm